<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P10448285A1035 The median durations for response and survival time in the late phase II trial were 2.3 months and 5.8 months, respectively."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="139" language="x-unspecified"/></CAS>